Apex Labs Ltd.
PrivateLast Round
Series A
Feb 9, 2022
Est. Valuation
$16M
Total Funding Raised
$4M
Company Overview
Apex Labs Ltd. operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was a Series A round in February 2022.
Apex Labs Ltd. is a pharmaceutical company that develops and commercializes clinically evaluated psilocybin-derived treatments for depression, anxiety, and PTSD.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Mental Health, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apex Labs Ltd. Comparables
Compare Apex Labs Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reunion Neuroscience Inc. | 81% | |
| Lykos Therapeutics | 77% | |
| Helus Pharma | 76% |
For institutional investors. Book with your work email.
Apex Labs Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Apex Labs Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iter Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 9, 2022
$4M round led by Iter Investments.
For institutional investors. Book with your work email.
Apex Labs Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Apex Labs Ltd.'s valuation, stock price, and market status.
Is Apex Labs Ltd. a public or private company?
Apex Labs Ltd. is a private company.
What is the current stock price of Apex Labs Ltd.?
Apex Labs Ltd. is a private company, so its shares have no public market price. Caplight tracks Apex Labs Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Apex Labs Ltd. worth (valuation)?
Apex Labs Ltd.'s valuation is estimated at $16.0M based on funding round data.
Can I buy Apex Labs Ltd. stock?
Apex Labs Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Apex Labs Ltd.'s last funding round?
Apex Labs Ltd.'s most recent funding round was Series A on February 9, 2022.
Who are the main investors in Apex Labs Ltd.?
Key investors in Apex Labs Ltd. include Iter Investments.
Will Apex Labs Ltd. IPO soon?
No public IPO plans have been announced for Apex Labs Ltd..
How can I track Apex Labs Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Apex Labs Ltd.'s shares on secondary markets.